1. Home
  2. BBNX vs SITC Comparison

BBNX vs SITC Comparison

Compare BBNX & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • SITC
  • Stock Information
  • Founded
  • BBNX 2015
  • SITC 1965
  • Country
  • BBNX United States
  • SITC United States
  • Employees
  • BBNX N/A
  • SITC N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • SITC Real Estate Investment Trusts
  • Sector
  • BBNX Health Care
  • SITC Real Estate
  • Exchange
  • BBNX Nasdaq
  • SITC Nasdaq
  • Market Cap
  • BBNX 740.7M
  • SITC 600.0M
  • IPO Year
  • BBNX 2025
  • SITC 1993
  • Fundamental
  • Price
  • BBNX $17.05
  • SITC $12.21
  • Analyst Decision
  • BBNX Strong Buy
  • SITC Hold
  • Analyst Count
  • BBNX 10
  • SITC 8
  • Target Price
  • BBNX $24.40
  • SITC $35.25
  • AVG Volume (30 Days)
  • BBNX 811.1K
  • SITC 1.1M
  • Earning Date
  • BBNX 07-29-2025
  • SITC 08-05-2025
  • Dividend Yield
  • BBNX N/A
  • SITC 38.93%
  • EPS Growth
  • BBNX N/A
  • SITC N/A
  • EPS
  • BBNX N/A
  • SITC 6.74
  • Revenue
  • BBNX $69,830,000.00
  • SITC $173,351,000.00
  • Revenue This Year
  • BBNX $32.71
  • SITC N/A
  • Revenue Next Year
  • BBNX $37.37
  • SITC $5.90
  • P/E Ratio
  • BBNX N/A
  • SITC $1.75
  • Revenue Growth
  • BBNX 38911.17
  • SITC N/A
  • 52 Week Low
  • BBNX $8.89
  • SITC $10.46
  • 52 Week High
  • BBNX $24.50
  • SITC $18.15
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • SITC 63.23
  • Support Level
  • BBNX N/A
  • SITC $11.39
  • Resistance Level
  • BBNX N/A
  • SITC $12.06
  • Average True Range (ATR)
  • BBNX 0.00
  • SITC 0.28
  • MACD
  • BBNX 0.00
  • SITC 0.10
  • Stochastic Oscillator
  • BBNX 0.00
  • SITC 99.54

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About SITC SITE Centers Corp.

SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.

Share on Social Networks: